Vigorous Stocks Need to Consider: CVS Health (NYSE:CVS), American International Group (NYSE:AIG)

CVS Health Corporation (NYSE:CVS) [Trend Analysis] retains strong position in active trade, as shares scoring -0.42% to $80.70 in active trade session, while looking at the shares volume, around 5.38 Million shares have changed hands in this session. CVS Health (CVS) reported that CVS Pharmacy locations in four additional states will dispense the opioid overdose reversal drug naloxone to patients without an individual prescription. With the addition of CVS Pharmacy locations in Arizona, Georgia, Iowa and South Carolina, CVS Pharmacy locations in 41 states are now able to increase access to the life-saving medication.

Georgia, Iowa and South Carolina all allow pharmacists to dispense naloxone under a standing order from a physician. Arizona regulations give pharmacists prescriptive authority to dispense the medication. “CVS Health is committed to addressing and preventing opioid abuse in the communities we serve and increasing access to this life-saving medication is an important part of that commitment,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery.” The firm has institutional ownership of 86.30%, while insider ownership included 0.10%. CVS attains analyst recommendation of 2.00 with week’s performance of -0.80%. Investors looking further ahead will note that the Price to next year’s EPS is 8.86%.

Shares of American International Group, Inc. (NYSE:AIG) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -0.36% to close at $63.21. American International Group (AIG) reported Peter Hancock, President and CEO, has informed the Board of his intention to resign. Hancock will remain as CEO until a successor has been named. The Board will conduct a comprehensive search for a successor to Hancock.

“I believe this is the right decision to make for the company and all its stakeholders. Without wholehearted shareholder support for my continued leadership, a protracted period of uncertainty could undermine the progress we have made and damage the interests of our policyholders, employees, regulators, debtholders, and shareholders,” Hancock said.Hancock was named President and CEO of AIG in September, 2014. Moving forward to saw long-term intention, the experts calculate Return on Investment of 0.40%. The stock is going forward its fifty-two week low with 31.94% and lagging behind from its 52-week high price with -6.31%. AIG last month stock price volatility remained 1.48%.

 

About Aaron Smithies

Aaron Smithies has a wide look on current monetary and financial events. He is an editor and a writer. His views; At Streetwise Report, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Interests: Biotech, Finical markets, Dividend stock ideas & income, Energy stocks, Consumer goods stocks

Leave a Reply

Your email address will not be published. Required fields are marked *